Literature DB >> 34727554

Scientific Evidence Supporting Coronavirus Disease 2019 (COVID-19) Vaccine Efficacy and Safety in People Planning to Conceive or Who Are Pregnant or Lactating.

Guillermina Girardi1, Andrew A Bremer.   

Abstract

Three coronavirus disease 2019 (COVID-19) vaccines have been authorized for use in the United States; specifically, the Pfizer-BioNTech, Moderna, and Johnson & Johnson-Janssen COVID-19 vaccines were granted emergency use authorization by the U.S. Food and Drug Administration in late 2020 and early 2021. Vaccination coverage and intent among adults are lowest among those aged 18-39 years and among females in particular. In females of reproductive age, enthusiasm for receiving a COVID-19 vaccine may be negatively affected by claims currently circulating widely on diverse social media platforms regarding the vaccines adversely affecting fertility and pregnancy. Yet it is important to note that these claims are anecdotal in nature and not supported by the available scientific evidence. It is also imperative that the effects of COVID-19 vaccine on reproductive health are clarified. Herein, we discuss the existing scientific data supporting COVID-19 vaccine safety and efficacy in people who are planning to conceive or who are pregnant or lactating and highlight the importance of COVID-19 vaccination in females of reproductive age.
Copyright © 2021 Written work prepared by employees of the Federal Government as part of their official duties is, under the U.S. Copyright Act, a “work of the United States Government” for which copyright protection under Title 17 of the United States Code is not available. As such, copyright does not extend to the contributions of employees of the Federal Government. Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34727554      PMCID: PMC8678336          DOI: 10.1097/AOG.0000000000004636

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  32 in total

1.  Involving Pregnant Individuals in Clinical Research on COVID-19 Vaccines.

Authors:  Diana W Bianchi; Lisa Kaeser; Alison N Cernich
Journal:  JAMA       Date:  2021-03-16       Impact factor: 56.272

2.  SARS-CoV-2-Specific Antibodies in Breast Milk After COVID-19 Vaccination of Breastfeeding Women.

Authors:  Sivan Haia Perl; Atara Uzan-Yulzari; Hodaya Klainer; Liron Asiskovich; Michal Youngster; Ehud Rinott; Ilan Youngster
Journal:  JAMA       Date:  2021-05-18       Impact factor: 56.272

3.  Maternal Outcomes After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Vaccinated Compared With Unvaccinated Pregnant Patients.

Authors:  John A Morgan; Joseph R Biggio; Jane K Martin; Naiha Mussarat; Harsheen K Chawla; Priya Puri; Frank B Williams
Journal:  Obstet Gynecol       Date:  2022-01-01       Impact factor: 7.661

4.  Maternal and Child Outcomes Reported by Breastfeeding Women Following Messenger RNA COVID-19 Vaccination.

Authors:  Kerri Bertrand; Gordon Honerkamp-Smith; Christina D Chambers
Journal:  Breastfeed Med       Date:  2021-08-31       Impact factor: 2.335

5.  Fetal and Perinatal Mortality: United States, 2013.

Authors:  Marian F MacDorman; Elizabeth C W Gregory
Journal:  Natl Vital Stat Rep       Date:  2015-07-23

6.  SARS-CoV-2 spike protein seropositivity from vaccination or infection does not cause sterility.

Authors:  Randy S Morris
Journal:  F S Rep       Date:  2021-06-02

7.  Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination in Pregnancy: Measures of Immunity and Placental Histopathology.

Authors:  Elisheva D Shanes; Sebastian Otero; Leena B Mithal; Chiedza A Mupanomunda; Emily S Miller; Jeffery A Goldstein
Journal:  Obstet Gynecol       Date:  2021-08-01       Impact factor: 7.661

8.  Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study.

Authors:  Kathryn J Gray; Evan A Bordt; Caroline Atyeo; Elizabeth Deriso; Babatunde Akinwunmi; Nicola Young; Aranxta Medina Baez; Lydia L Shook; Dana Cvrk; Kaitlyn James; Rose De Guzman; Sara Brigida; Khady Diouf; Ilona Goldfarb; Lisa M Bebell; Lael M Yonker; Alessio Fasano; S Alireza Rabi; Michal A Elovitz; Galit Alter; Andrea G Edlow
Journal:  Am J Obstet Gynecol       Date:  2021-03-26       Impact factor: 8.661

9.  Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-October 3, 2020.

Authors:  Laura D Zambrano; Sascha Ellington; Penelope Strid; Romeo R Galang; Titilope Oduyebo; Van T Tong; Kate R Woodworth; John F Nahabedian; Eduardo Azziz-Baumgartner; Suzanne M Gilboa; Dana Meaney-Delman
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-11-06       Impact factor: 17.586

10.  COVID-19 Vaccine Roll-Out in South Africa and Zimbabwe: Urgent Need to Address Community Preparedness, Fears and Hesitancy.

Authors:  Tafadzwa Dzinamarira; Brian Nachipo; Bright Phiri; Godfrey Musuka
Journal:  Vaccines (Basel)       Date:  2021-03-12
View more
  6 in total

Review 1.  Menstrual abnormalities after COVID-19 vaccines: A systematic review.

Authors:  Maheen Nazir; Shumaila Asghar; Muhammad Ali Rathore; Asima Shahzad; Anum Shahid; Alishba Ashraf Khan; Asmara Malik; Tehniat Fakhar; Hafsa Kausar; Jahanzeb Malik
Journal:  Vacunas       Date:  2022-07-19

2.  Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Pregnancy in Sub-Saharan Africa: A 6-Country Retrospective Cohort Analysis.

Authors:  Jean B Nachega; Nadia A Sam-Agudu; Rhoderick N Machekano; Philip J Rosenthal; Sonja Schell; Liesl de Waard; Adrie Bekker; Onesmus W Gachuno; John Kinuthia; Nancy Mwongeli; Samantha Budhram; Valerie Vannevel; Priya Somapillay; Hans W Prozesky; Jantjie Taljaard; Arifa Parker; Elizabeth Agyare; Akwasi Baafuor Opoku; Aminatu Umar Makarfi; Asara M Abdullahi; Chibueze Adirieje; Daniel Katuashi Ishoso; Michel Tshiasuma Pipo; Marc B Tshilanda; Christian Bongo-Pasi Nswe; John Ditekemena; Lovemore Nyasha Sigwadhi; Peter S Nyasulu; Michel P Hermans; Musa Sekikubo; Philippa Musoke; Christopher Nsereko; Evans K Agbeno; Michael Yaw Yeboah; Lawal W Umar; Mukanire Ntakwinja; Denis M Mukwege; Etienne Kajibwami Birindwa; Serge Zigabe Mushamuka; Emily R Smith; Edward J Mills; John Otokoye Otshudiema; Placide Mbala-Kingebeni; Jean-Jacques Muyembe Tamfum; Alimuddin Zumla; Aster Tsegaye; Alfred Mteta; Nelson K Sewankambo; Fatima Suleman; Prisca Adejumo; Jean R Anderson; Emilia V Noormahomed; Richard J Deckelbaum; Jeffrey S A Stringer; Abdon Mukalay; Taha E Taha; Mary Glenn Fowler; Judith N Wasserheit; Refiloe Masekela; John W Mellors; Mark J Siedner; Landon Myer; Andre-Pascal Kengne; Marcel Yotebieng; Lynne M Mofenson; Eduard Langenegger
Journal:  Clin Infect Dis       Date:  2022-06-08       Impact factor: 20.999

3.  Covid-19 vaccination and menstrual cycle length in the Apple Women's Health Study.

Authors:  Elizabeth A Gibson; Huichu Li; Victoria Fruh; Malaika Gabra; Gowtham Asokan; Anne Marie Z Jukic; Donna D Baird; Christine L Curry; Tyler Fischer-Colbrie; Jukka-Pekka Onnela; Michelle A Williams; Russ Hauser; Brent A Coull; Shruthi Mahalingaiah
Journal:  medRxiv       Date:  2022-07-10

4.  Corona and Reproduction, or Why the Corona Vaccination Does Not Result in Infertility.

Authors:  Anne-Sophie Braun; Katharina Feil; Elisabeth Reiser; Guenter Weiss; Thore von Steuben; Germar Michael Pinggera; Frank-Michael Köhn; Bettina Toth
Journal:  Geburtshilfe Frauenheilkd       Date:  2022-05-06       Impact factor: 2.754

5.  Menstrual irregularities and vaginal bleeding after COVID-19 vaccination reported to v-safe active surveillance, USA in December, 2020-January, 2022: an observational cohort study.

Authors:  Karen K Wong; Charles M Heilig; Anne Hause; Tanya R Myers; Christine K Olson; Julianne Gee; Paige Marquez; Penelope Strid; David K Shay
Journal:  Lancet Digit Health       Date:  2022-08-09

6.  COVID-19 vaccine and menstrual conditions in female: data analysis of the Vaccine Adverse Event Reporting System (VAERS).

Authors:  Bing Zhang; Xiao Yu; Jinxing Liu; Jinbao Liu; Pengfei Liu
Journal:  BMC Womens Health       Date:  2022-10-05       Impact factor: 2.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.